– Barclays Gene Editing & Gene Therapy Summit on November 16 at 1:00pm ET
– Stifel 2020 Virtual Healthcare Conference on November 17 at 2:00pm ET
– Jefferies Virtual London Healthcare Conference on November 17 at 1:10pm ET/6:10pm GMT
PR Newswire
SAN RAFAEL, Calif., Nov. 12, 2020 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in three upcoming virtual conferences. An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company’s portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com. Information on BioMarin’s website is not incorporated by reference into this press release.
|
Contacts: |
|
|
Investors |
Media |
|
|
Debra Charlesworth |
|
|
BioMarin Pharmaceutical Inc. |
|
|
(415) 455-7451 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-three-upcoming-virtual-investor-conferences-301171792.html
SOURCE BioMarin Pharmaceutical Inc.
